Craig B Granowitz Lexicon Pharmaceuticals, Inc. (LXRX) insider trading activity

LXRX Quotes by TradingView

Craig B Granowitz is SVP, Chief Medical Officer of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 47,626 shares of LXRX, which is worth approximately $36,672. The most recent transaction as insider was on Feb 28, 2024, when has been sold 31,265 shares (Common Stock) at a price of $2.62 per share, resulting in proceeds of $81,914. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.6K
0% 3M change
213.64% 12M change
Total Value Held $36,672

Craig B Granowitz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2024
SELL
Payment of exercise price or tax liability
$81,914 $2.62 p/Share
31,265 Reduced 39.63%
47,626 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
63,706 Added 44.68%
78,891 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$27,628 $2.17 p/Share
12,732 Reduced 45.61%
15,185 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
-
27,917 Added 50.0%
27,917 Common Stock
CBG

Craig B Granowitz

SVP, Chief Medical Officer
The Woodlands, TX

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LXRX